MyFinsight
Home
Blog
About
Back
Income Statement
Eledon Pharmaceuticals, Inc. (ELDN)
Eledon Pharmaceuticals, Inc. (ELDN)
source: myfinsight.com
Net loss
-$31,630K
(-182.01%↓ Y/Y)
Other income, net
$862K
(-29.58%↓ Y/Y)
Loss from operations
-$22,869K
(7.54%↑ Y/Y)
Change in fair value of
warrant liabilities
$9,623K
(178.28%↑ Y/Y)
Total operating
expenses
$22,869K
(-7.54%↓ Y/Y)
Research and development
$18,230K
(-10.09%↓ Y/Y)
General and
administrative
$4,639K
(4.08%↑ Y/Y)
Back